Filing Details

Accession Number:
0001127602-16-059802
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-08-09 09:23:11
Reporting Period:
2016-08-05
Filing Date:
2016-08-09
Accepted Time:
2016-08-09 09:23:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1472091 Edge Therapeutics Inc. EDGE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1214501 Bradford W Middlekauff 200 Connell Drive
Suite 1600
Berkeley Heights NJ 07922
Senior Vp, Gc And Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-08-05 9,857 $9.48 9,857 No 4 P Direct
Common Stock Acquisiton 2016-08-08 143 $9.43 10,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $9.42 to $9.60 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.